Atlas Trials

Clene Nanomedicine

12 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Clene Nanomedicine

RecordFirmDate
An Open-Label Extension for the Phase 2 Study in Early Symptomatic Amyotrophic Lateral Sclerosis Patients on Stable Background Therapy to Assess Bioenergetic Catalysis With CNM-Au8 to Slow Disease Progression in ALS (NCT05299658)Clene Nanomedicine2021-11-13
Study of ZnAg Liquid Solution to Treat COVID-19 Symptomatic Participants (NCT04610138)Clene Nanomedicine2021-06-01
A Multi-Center, Open-Label Long-Term Extension Study of CNM-Au8 In Patients With Stable Relapsing Multiple Sclerosis (NCT04626921)Clene Nanomedicine2020-10-22
31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Amyotrophic Lateral Sclerosis (REPAIR-ALS) (NCT03843710)Clene Nanomedicine2020-03-01
31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Multiple Sclerosis. (NCT03993171)Clene Nanomedicine2019-12-19
31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Parkinson's Disease (NCT03815916)Clene Nanomedicine2019-12-19
Therapeutic Nanocatalysis to Slow Disease Progression of Amyotrophic Lateral Sclerosis (ALS) (NCT04098406)Clene Nanomedicine2019-12-19
Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis (NCT03536559)Clene Nanomedicine2018-11-23

Track Clene Nanomedicine automatically

Every clearance here is in the API, with alerts when new ones post.